Gisslén M - Search Results

1

Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.

Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M. Mellgren A, et al. Among authors: gisslen m. Antivir Ther. 2005;10(6):701-7. Antivir Ther. 2005. PMID: 16218168 Clinical Trial.

2

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.

Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslén M. Abdulle S, et al. Among authors: gisslen m. AIDS. 2002 Nov 8;16(16):2145-9. doi: 10.1097/00002030-200211080-00006. AIDS. 2002. PMID: 12409735

3

[Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result].

Gisslén M, Sönnerborg A. Gisslén M, et al. Lakartidningen. 2002 Oct 24;99(43):4263-6. Lakartidningen. 2002. PMID: 12448313 Swedish.

4

pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.

Brandin E, Lindborg L, Gyllensten K, Broström C, Hagberg L, Gisslen M, Tuvesson B, Blaxhult A, Albert J. Brandin E, et al. Among authors: gisslen m. AIDS Res Hum Retroviruses. 2003 Jul;19(7):543-50. doi: 10.1089/088922203322230905. AIDS Res Hum Retroviruses. 2003. PMID: 12908931

5

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.

Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. Cinque P, et al. Among authors: gisslen m. Ann Neurol. 2004 May;55(5):687-94. doi: 10.1002/ana.20076. Ann Neurol. 2004. PMID: 15122709

6

Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2 infection.

Arvidson N, Gisslén M, Albert J, Brandin E, Svennerholm B, Fuchs D, Hagberg L. Arvidson N, et al. Among authors: gisslen m. AIDS Res Hum Retroviruses. 2004 Jul;20(7):711-5. doi: 10.1089/0889222041524625. AIDS Res Hum Retroviruses. 2004. PMID: 15307916

7

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.

Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Sidenius N, et al. Among authors: gisslen m. J Neuroimmunol. 2004 Dec;157(1-2):133-9. doi: 10.1016/j.jneuroim.2004.08.038. J Neuroimmunol. 2004. PMID: 15579290

8

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.

Yilmaz A, Ståhle L, Hagberg L, Svennerholm B, Fuchs D, Gisslén M. Yilmaz A, et al. Among authors: gisslen m. Scand J Infect Dis. 2004;36(11-12):823-8. doi: 10.1080/00365540410025320. Scand J Infect Dis. 2004. PMID: 15764168 Clinical Trial.

9

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.

Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. Cinque P, et al. Among authors: gisslen m. J Neuroimmunol. 2005 Nov;168(1-2):154-63. doi: 10.1016/j.jneuroim.2005.07.002. Epub 2005 Aug 8. J Neuroimmunol. 2005. PMID: 16091292

10

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection.

Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW. Gisslén M, et al. AIDS Res Ther. 2005 Aug 18;2:6. doi: 10.1186/1742-6405-2-6. AIDS Res Ther. 2005. PMID: 16109178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters